Patient Resources

Below are a list of resources provided to patient groups to support their advocacy and activities.

Where possible, the information is available in multiple languages 

Just click on the links to take you to the relevant pages

• Press releases and summaries  (2020 -2025)

• Corporate Reputation of Pharma – Asia Press Release 2024/25 (Chinese)

• Corporate Reputation of Pharma – Asia Press Release 2024/25 (Japanese)

• Patients and the power of their collective voice

• Participação ativa: pacientes e o poder de sua voz coletiva (Medicina S/A)

• Industria farmacéutica: los pacientes y el poder de su voz colectiva (Forbes Argentina)

• Corporate Reputation of Pharma – Italian Press Release (2024/25)

• Corporate Reputation of Pharma – Spanish Press Release (2024/25)

• Corporate Reputation of Pharma – German Press Release (2024/25)

• Corporate Reputation of Pharma – French Press Release (2024/25)

• Corporate Reputation of Pharma – Portuguese Press Release (2024/25)

• Corporate Reputation of Pharma – Spanish Press Release (2024/25)

• Patient Groups and ESG (2025)

• Patient Groups and Health Technology Assessments (2024)

• Patients in Action – a focus on breast cancer patient groups

• Corporate Reputation of Pharma – Patient Summaries (2023/2024)

• Patients in Action: Tackling the Healthcare Crisis (2024)

• The Patient Movement in Numbers — a Focus on Brazil (2024)

• How Pharma needs to improve, according to patient groups in Asia-Pacific (2024)

• Patient groups at the heart of healthcare: a vital partnership for a healthier world (2024)

• Guiding Health Policy: Perspectives from People living with Obesity, in collaboration with Novo Nordisk (2024)

• Patient-groups in Ukraine (2023)

• Webinar: A timely diagnosis for Alzheimer’s disease (2023)

• Report: A timely diagnosis for Alzheimer’s disease (2022)

• Patient-group case studies and stories (2021 onwards)